|
TORONTO, ONTARIO--(Marketwire - July 18, 2012) - Trimel Pharmaceuticals Corporation (TSX:TRL) (the "Corporation") is pleased to announce that the Corporation and its subsidiaries have entered into a loan and security agreement with GE Capital, Healthcare Financial Services ("GE Capital"), as agent for the lenders party thereto, pursuant to which GE Capital will advance U.S.$7,500,000 (the "Loan") to the Corporation. The Corporation intends to use the net proceeds from the Loan for general corporate purposes. |
